GB

Govindsingh Bhavansinh Chavda

Active Director Director DIN 07931885
DIN 07931885 First appointment Jan 2018 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Jan 2018
Shareholding value •••• Premium profile

About Govindsingh Bhavansinh Chavda

Data last updated:

Govindsingh Bhavansinh Chavda has 8 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Celliimune Therapeutics Private Limited and Axon Group Holdings Private Limited. Formerly with 4 companies, such as Infinion Biopharma Limited and Aashirwad Foodtech Private Limited. Engaged in General Business, Technology and more. The largest current company by reported revenue is Amphina Therapeutics Private Limited at ₹0.25 Cr (FY 2025).

DIN 07931885
Primary Designation Director
First Appointment 16 Jan 2018
Oldest Company Age 6 yrs
Largest company Amphina Therapeutics Private Limited · ₹0.25 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amphina Therapeutics Private Limited U85100GJ2020PTC112901
Whole-Time Director24 Feb 20202020₹0.25 Cr (FY 2025)Active
Axon Group Holdings Private Limited U65999GJ2023PTC138118
Director05 Jan 20232023–Active
Director26 May 20222022–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Infinion Biopharma Limited U51909GJ2018PLC100571
Director16 Jan 20182018₹0.92 Cr (FY 2025)Active
Aashirwad Foodtech Private Limited U55101GJ2019PTC109031
Director10 Jul 20192019–Active
Innovate Farmkart Private Limited U85300GJ2020PTC112885
Director21 Feb 20202020–Active
Axon Finance And Securities Limited U65910GJ1994PLC023782
Director12 Aug 20191994₹1.25 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Celliimune Therapeutics Private Limited
Axon Group Holdings Private Limited
Amphina Therapeutics Private Limited
Infinion Biopharma Limited
Premium access

Shareholding and investment profile for Govindsingh Bhavansinh Chavda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Govindsingh Bhavansinh Chavda

Govindsingh Bhavansinh Chavda has 8 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Celliimune Therapeutics Private Limited and Axon Group Holdings Private Limited. Formerly with 4 companies, such as Infinion Biopharma Limited and Aashirwad Foodtech Private Limited. Engaged in General Business, Technology and more. The largest current company by reported revenue is Amphina Therapeutics Private Limited at ₹0.25 Cr (FY 2025).

Govindsingh Bhavansinh Chavda is associated with 3 companies as Director and Whole-Time Director, including Amphina Therapeutics Private Limited (₹0.25 Cr), Axon Group Holdings Private Limited, Celliimune Therapeutics Private Limited.

Govindsingh Bhavansinh Chavda has expertise in General Business, Technology and other sectors.

Govindsingh Bhavansinh Chavda has 8 years in corporate governance.

By reported revenue, the largest current company of Govindsingh Bhavansinh Chavda is Amphina Therapeutics Private Limited, with revenue of ₹0.25 Cr (FY 2025).

Govindsingh Bhavansinh Chavda currently holds positions at 3 companies: Amphina Therapeutics Private Limited (₹0.25 Cr), Axon Group Holdings Private Limited, Celliimune Therapeutics Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available